Stocks · Health care · Services-Commercial Physical & Biological Research

MAXCYTE, INC.

MXCT Clue Score24
United States Fiscal year ends December CIK 0001287098 Results filed 14 Oct 2026

What the insiders did Net selling

By person

13 insiders · 1 transaction
0.6×

Maher Masoud holds only 0.6 times base salary in stock. $387.13K of shares against $590.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Maher Masoud last reported holding, valued at $0.82, the price Common Stock was last bought or sold at on the open market here, on 17 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Douglas J Swirsky
Chief Financial Officer
—
$8.27K (1)
−$8.27K
151,669
0.1470%
$123.61K
+86.7%
Maher Masoud
President and CEO
—
—
—
475,000
0.4602%
$387.13K
+375.0%
Stanley C Erck
Director
—
—
—
428,749
0.4154%
$349.43K
+59.3%
Richard Douglas
Director
—
—
—
260,998
0.2529%
$212.71K
+115.0%
John Joseph Johnston
Director
—
—
—
201,581
0.1953%
$164.29K
+42.0%
Parmeet Ahuja
Chief Financial Officer
—
—
—
187,500
0.1817%
$152.81K
—
William W Brooke
Director
—
—
—
181,300
0.1757%
$147.76K
+153.0%
Cynthia Collins
Director
—
—
—
111,310
0.1079%
$90.72K
+115.4%
Patrick J Balthrop
Director
—
—
—
80,998
0.0785%
$66.01K
+279.1%
Yasir B. Al-Wakeel
Director
—
—
—
80,998
0.0785%
$66.01K
+279.1%
Rekha Hemrajani
Director
—
—
—
70,314
0.0681%
$57.31K
+229.1%
David I. Sandoval
General Counsel
—
—
—
64,219
0.0622%
$52.34K
+39.9%
Ali Soleymannezhad
Chief Commercial Officer
—
—
—
59,439
0.0576%
$48.44K
+128.4%